推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733，021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Elevated Levels Of Lung Epithelial Lining Fluid Urokinase Activity Is Associated With Both Emphysema And HIV-1 Infection

RJ Kaner, JM Hu… - American Journal of Respiratory …, 2011 - Am Thoracic Soc
/ Poster Discussion Session / Sunday, May 15/2:00 PM-4:30 PM / A107 NEW CONCEPTS IN
PROTEASES AND ANTIPROTEASES Korbel Ballroom 1A-1B (Lower Level), Colorado Convention
Center ... Elevated Levels Of Lung Epithelial Lining Fluid Urokinase Activity Is Associated ...
All 3 versions

Urokinase Plasminogen Activator Receptor in Adipose Tissue Macrophages of Morbidly Obese Subjects

R Cancello, C Rouault, G Guilhem, JF Bedel… - Obesity …, 2011 - content.karger.com
Objective: At present, circulating markers characterizing the inflammatory infiltration of white
adipose tissue (WAT) in human obesity are not well known. We previously identified, by a pangenomic
approach (microarrays), the urokinase plasminogen activator receptor (PLAUR or CD87) ...
Cited by 1 - Related articles - All 2 versions

Clinical Applications of the Urokinase Receptor (uPAR) for Cancer Patients.

MC Boonstra, HW Verspaget, S Ganesh… - Current …, 2011 - ncbi.nlm.nih.gov
Since decades the urokinase plasminogen activator (uPA) system has been associated with
the invasion of malignant cells. The receptor of urokinase (uPAR) is one of the key players in
this proteolytic cascade, because it focuses uPA's proteolytic activity to the cell surface ...

Monoclonal antibodies specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor

M Resnati, F Blasi, N Sidenius… - US Patent 7,951,589, 2011 - Google Patents
Page 1. mi iiiiiii ill mi mi mi mil mi mi mi (12) United States Patent Resnati et al. (io) Patent No.:
(45) Date of Patent: US 7,951,589 B2 May 31, 2011 (54) MONOCLONAL ANTIBODIES SPECIFIC
FOR THE CHEMOTACTIC EPITOPE OF THE UROKINASE-TYPE PLASMINOGEN ...
Related articles - All 3 versions

Soluble urokinase plasminogen activator receptor during allogeneic stem cell transplantation

E Haastrup, J Andersen… - Scandinavian …, 2011 - Wiley Online Library
Previous studies have found that soluble urokinase plasminogen activation receptor
(suPAR) increases during inflammatory and malignant illness and elevated suPAR levels may
be associated with poor clinical outcome. The purpose of this study was to investigate ...
Related articles - All 2 versions

联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

© 2010-2024 中国: LetPub上海分公司    网站备案号：沪ICP备10217908号-1    沪公网安备号：31010402006960

增值电信业务经营许可证：沪B2-20211595

礼翰商务信息咨询（上海）有限公司      办公地址：上海市徐汇区漕溪北路88号圣爱大厦1803室

United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451